Jack Chia Industries (Thailand) Public (JCT) Fundamentals 2026 — P/E 9.1x, Revenue Analysis | SniperIQ
Jack Chia Industries (Thailand) Public (JCT) is a TH-listed Healthcare company in Medical - Pharmaceuticals with a market capitalization of ฿1.1B, trading at ฿83.00 on the SET. This SniperIQ fundamentals page covers Jack Chia Industries (Thailand) Public's valuation (P/E 9.1x, P/B 0.8x), profitability (net margin 13.9%), revenue (฿872M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Jack Chia Industries (Thailand) Public's market cap?
Jack Chia Industries (Thailand) Public (JCT) has a market capitalization of approximately ฿1.1B, trading at ฿83.00 on the SET. Market cap moves with the live share price.
What is Jack Chia Industries (Thailand) Public's P/E ratio?
Jack Chia Industries (Thailand) Public's trailing twelve-month P/E ratio is 9.1x, with a price-to-book (P/B) of 0.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Jack Chia Industries (Thailand) Public?
Jack Chia Industries (Thailand) Public runs a net profit margin of 13.9%, a gross margin of 44.9%, and an operating margin of 14.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Jack Chia Industries (Thailand) Public generate?
Jack Chia Industries (Thailand) Public reported revenue of ฿872M for fiscal year 2025, with net income of ฿116M and earnings per share (EPS) of 8.59. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Jack Chia Industries (Thailand) Public pay a dividend?
Jack Chia Industries (Thailand) Public offers a trailing dividend yield of about 5.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Jack Chia Industries (Thailand) Public financially healthy?
Jack Chia Industries (Thailand) Public carries a debt-to-equity ratio of 0.00x and a current ratio of 11.18x, with a market beta of 0.07. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Jack Chia Industries (Thailand) Public a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Jack Chia Industries (Thailand) Public (JCT) the key facts are: market cap ฿1.1B, P/E 9.1x, revenue ฿872M, 52-week range 78-90. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Jack Chia Industries (Thailand) Public's full fundamentals live
Get Jack Chia Industries (Thailand) Public's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.